Clinical trials
Blood Coagulation Disorders trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2010 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Recruiting | 2 |
| Unknown status | 2 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ottawa Hospital Research Institute | 2 |
| Spark Therapeutics, Inc. | 2 |
| Baxalta now part of Shire | 1 |
| Bayer | 1 |
| Boston Children's Hospital | 1 |
| Genzyme, a Sanofi Company | 1 |
| Nova Scotia Health Authority | 1 |
| Novartis Pharmaceuticals | 1 |
| Queen's University | 1 |
| Sierra Oncology LLC - a GSK company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Blood Coagulation Disorders | 15 |
| Hematologic Diseases | 9 |
| Hemorrhagic Disorders | 7 |
| Blood Coagulation Disorders, Inherited | 4 |
| Coagulation Protein Disorders | 4 |
| Hemophilia A | 4 |
| Blood Platelet Disorders | 3 |
| Genetic Diseases, Inborn | 3 |
| Genetic Diseases, X-Linked | 3 |
| Hemostatic Disorders | 3 |
Trials
Showing 26 to 15 of 15. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.